BM-MSC-CM and WJ-MSC-CM were major sources of cytokines and growth factors, especially proangiogenic agents including PDGF, HGF, FGF, MCP-1, IL-8, and IL-6, and these media could represent an ideal device for clinical applications in SSc. The gene discussed is CCL2; the disease is systemic sclerosis.